| (NOK) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | -100.00% |
| Operating expense | — | — |
| Net income | -155.07M | 10.61% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ONCIN.OL returned +16.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +71.5% |
| 1 year | +16.3% |
| 5 years | -99.9% |
| All-time high | kr 272,043.69 (May 2018) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what kr1,000 in ONCIN.OL would be worth today ›No. Oncoinvent ASA has not paid a dividend in the past 12 months.
Oncoinvent ASA is part of the Healthcare sector.
Oncoinvent ASA has a market cap of 377.08M NOK, based on the latest quote.
Oncoinvent ASA is scheduled to report earnings on Aug 27, 2026.